Omniab Inc Stock Performance
| OABI Stock | USD 1.61 0.12 8.05% |
The company holds a Beta of 2.76, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, OmniAb will likely underperform. At this point, OmniAb Inc has a negative expected return of -0.26%. Please make sure to check OmniAb's kurtosis, and the relationship between the maximum drawdown and rate of daily change , to decide if OmniAb Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days OmniAb Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in December 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
| Begin Period Cash Flow | 16.9 M | |
| Total Cashflows From Investing Activities | 37.9 M |
OmniAb Relative Risk vs. Return Landscape
If you would invest 200.00 in OmniAb Inc on August 14, 2025 and sell it today you would lose (39.00) from holding OmniAb Inc or give up 19.5% of portfolio value over 90 days. OmniAb Inc is currently does not generate positive expected returns and assumes 4.0305% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than OmniAb, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
OmniAb Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for OmniAb's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as OmniAb Inc, and traders can use it to determine the average amount a OmniAb's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0651
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OABI |
Estimated Market Risk
| 4.03 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average OmniAb is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of OmniAb by adding OmniAb to a well-diversified portfolio.
OmniAb Fundamentals Growth
OmniAb Stock prices reflect investors' perceptions of the future prospects and financial health of OmniAb, and OmniAb fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on OmniAb Stock performance.
| Return On Equity | -0.22 | ||||
| Return On Asset | -0.13 | ||||
| Operating Margin | (8.10) % | ||||
| Current Valuation | 160.23 M | ||||
| Shares Outstanding | 143.96 M | ||||
| Price To Book | 0.72 X | ||||
| Price To Sales | 10.17 X | ||||
| Revenue | 26.39 M | ||||
| EBITDA | (50.92 M) | ||||
| Total Debt | 23.16 M | ||||
| Debt To Equity | 0.11 % | ||||
| Book Value Per Share | 1.93 X | ||||
| Cash Flow From Operations | (39.66 M) | ||||
| Earnings Per Share | (0.59) X | ||||
| Total Asset | 325.56 M | ||||
| Retained Earnings | (101.4 M) | ||||
About OmniAb Performance
By evaluating OmniAb's fundamental ratios, stakeholders can gain valuable insights into OmniAb's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if OmniAb has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if OmniAb has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company was founded in 2012 and is headquartered in Emeryville, California. Amniab operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 74 people.Things to note about OmniAb Inc performance evaluation
Checking the ongoing alerts about OmniAb for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for OmniAb Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| OmniAb Inc generated a negative expected return over the last 90 days | |
| OmniAb Inc may become a speculative penny stock | |
| OmniAb Inc has high historical volatility and very poor performance | |
| OmniAb Inc currently holds 23.16 M in liabilities with Debt to Equity (D/E) ratio of 0.11, which may suggest the company is not taking enough advantage from borrowing. OmniAb Inc has a current ratio of 0.56, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about OmniAb's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 26.39 M. Net Loss for the year was (62.03 M) with profit before overhead, payroll, taxes, and interest of 20.8 M. | |
| OmniAb generates negative cash flow from operations | |
| OmniAb Inc has a frail financial position based on the latest SEC disclosures | |
| About 13.0% of OmniAb outstanding shares are owned by corporate insiders |
- Analyzing OmniAb's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether OmniAb's stock is overvalued or undervalued compared to its peers.
- Examining OmniAb's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating OmniAb's management team can have a significant impact on its success or failure. Reviewing the track record and experience of OmniAb's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of OmniAb's stock. These opinions can provide insight into OmniAb's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for OmniAb Stock analysis
When running OmniAb's price analysis, check to measure OmniAb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OmniAb is operating at the current time. Most of OmniAb's value examination focuses on studying past and present price action to predict the probability of OmniAb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OmniAb's price. Additionally, you may evaluate how the addition of OmniAb to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |